bg
T

Taysha Gene Therapies (TSHA)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Taysha Gene Therapies (TSHA)

Taysha Gene Therapies, Inc. is a patient-centric gene therapy company. The Company is focused on developing and commercializing adeno-associated virus (AAV)-based gene therapies for the treatment of monogenic diseases of the central nervous system (C... Read more

  • USD2.35
  • USD2.45
  • USD2.29
  • USD3.89
  • -21.90%
  • 15M
  • 890.19k
  • 1.82M
  • 425M
  • 0.50
  • 264.00%

Stock News

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.

Get The App